𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

✍ Scribed by Baselga, José; Cortés, Javier; Kim, Sung-Bae; Im, Seock-Ah; Hegg, Roberto; Im, Young-Hyuck; Roman, Laslo; Pedrini, José Luiz; Pienkowski, Tadeusz; Knott, Adam; Clark, Emma; Benyunes, Mark C.; Ross, Graham; Swain, Sandra M.

Book ID
120047884
Publisher
Massachusetts Medical Society
Year
2012
Tongue
English
Weight
661 KB
Volume
366
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pertuzumab plus Trastuzumab plus Docetax
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
✍ Baselga, José; Cortés, Javier; Kim, Sung-Bae; Im, Seock-Ah; Hegg, Roberto; Im, Y 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 661 KB

## Background: The anti-human epidermal growth factor receptor 2 (her2) humanized monoclonal antibody trastuzumab improves the outcome in patients with her2-positive metastatic breast cancer. however, most cases of advanced disease eventually progress. pertuzumab, an anti-her2 humanized monoclonal